Rankings
▼
Calendar
LFMD FY 2023 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena
LFMD
LifeMD, Inc.
$182M
FY 2023 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$153M
+28.2% YoY
Gross Profit
$134M
87.6% margin
Operating Income
-$14M
-9.5% margin
Net Income
-$21M
-13.5% margin
EPS (Diluted)
$-0.70
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$86,948
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$58M
Total Liabilities
$53M
Stockholders' Equity
$4M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$153M
$119M
+28.2%
Gross Profit
$134M
$100M
+33.2%
Operating Income
-$14M
-$43M
+66.7%
Net Income
-$21M
-$46M
+54.8%
← Q4 2022
All Quarters
Q1 2023 →